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Abstract: Oxidative stress is a primary risk factor for both inflammatory 
and degenerative retinopathies. Our previous data on blue light-
irradiated retinas demonstrated an oxidative stress higher in the rod 
outer segment (OS) than in the inner limb, leading to impairment of the 
rod OS extra-mitochondrial aerobic metabolism.  
Here the oxidative metabolism and Reactive Oxygen Intermediates (ROI) 
production was evaluated in purified bovine rod OS in function of 
exposure to different illumination conditions.  A dose response was 
observed to varying light intensities and duration in terms of both ROI 
production and ATP synthesis. Pretreatment with resveratrol, inhibitor of 
F1Fo-ATP synthase, or metformin, inhibitor of the respiratory complex I, 
significantly diminished the ROI production. Metformin also diminished 
the rod OS Complex I activity and reduced the maximal OS response to 
light in ATP production.  
Data show for the first time the relationship existing in the rod OS 
between its -aerobic- metabolism, light absorption, and ROI production. A 
beneficial effect was exerted by metformin and resveratrol, in modulating 
the ROI production in the illuminated rod OS, suggestive of their 
beneficial action also in vivo. Data shed new light on preventative 
interventions for cone loss secondary to rod damage due to oxidative 
stress. 
 
 
 
 
 
Professor Rafael Radi, MD 
Associate Editor 
Free Radical Biology and Medicine  
Genoa, January , 17th 2018 
 
Dear Editor, 
thank you for Your interest in our manuscript  Free Radical Biology and Medicine 
Manuscript ID: FRBM-D-17-00543R2,  Entitled: MODULATION OF THE ROD OUTER SEGMENT 
AEROBIC METABOLISM DIMINISHES THE PRODUCTION OF RADICALS DUE TO LIGHT 
ABSORPTION. 
We are now ready to submit the revised manuscript. In the answer to reviewers the changes we 
have made and why are indicated in detail.  
 
Ph.D.  Daniela Calzia 
DIFAR-University of Genoa 
V.le Benedetto XV,3 
16132 GENOVA 
Phone + 39 010 353 7397 
Fax   + 39 010 353 8153 
dcalzia@gmail.com 
Cover Letter
 Reviewers' comments: 
Reviewer #1: I am glad the authors have followed my suggestion and happier still that this has proved 
useful!...  
We thank the reviewer for the good evaluation of our revised version of the manuscript. 
 
It would be useful to determine how the effects of metformin and resveratrol vary with their concentrations, as 
this might give some clue as to their utility in combatting oxidative stress in vivo.  However this is not a major 
concern. 
 
We are grateful to the Reviewer for his suggestion. Indeed, due to the very fast reaction kinetics of 
the DHR dye, in our opinion non-significant variations of ROI production related to different 
concentrations of resveratrol or metformin would be expected, by citofluorimetric analysis in the 
presence of concentrations of inhibitor that lay in the same order of magnitude. Furthermore, a 
dose-response study of the oxidative stress in a subcellular fraction, as rod outer segments are, 
may not be indicative for the determination of the best concentration of resveratrol or  metformin 
to recommend in the clinical practice to hinder the oxidative stress in vivo.  
Indeed, here we aimed at investigating for the first time the relationship among the rod outer 
segment (OS) aerobic metabolism and illumination, together with the related oxidative stress in an 
isolated system housing both photransduction and OXPHOS proteins, as the rod OS is.  In turn, 
Resveratrol and Metformin were used as known inhibitors of FoF1-ATP synthase and ETC Complex I 
respectively, allowing a negative control. Moreover, concerning Metformin, its therapeutic dose is 
only clinically determined, related to its hypoglycemic action. Notably, the novelty of the present 
study is to give a possible  experimental  and molecular explanation of the effect of Metformin 
(MTF) in effectively reducing the cumulative oxidative risk damage (a common pathogenic factors 
of diabetic retinopathy, DR) in type 2 diabetes mellitus patients MTF-treated.  
For these reasons, especially considering that the issue was not considered a major concern, we 
have preferred not to attempt those experiments.  
 
 It would be useful to redraw the graphic to emphasise the effects of light and on mitochondrial ROS 
production in RPE and rods as those unfamiliar with retinal anatomy would benefit from a fuller understanding 
of the crucial details of this separate but close association of these cells within the retina 
 
*Detailed Response to Reviewers
We are grateful to the Reviewer for his suggestion. We are agree with the Reviewer about the 
contribution of RPE mitochondria in the ROI production in the outer retina in vivo, in fact we 
mentioned this in the Discussion section.  
Therefore, considering that the Graphical Abstract should be representative of the paper data, as 
reported by FRBM “Guide for Authors “ (A graphical abstract is mandatory for this journal. It should 
summarize the contents of the article in a concise, pictorial form designed to capture the attention 
of a wide readership online. Authors must provide images that clearly represent the work described 
in the article.), addition of the RPE cells in the graphic may be in our opinion misleading about the 
content of the paper. In fact our experiments were not performed on whole retinas, rather on 
purified Rod OS, where RPE cells are absent and their contribution in the oxidative stress 
generation reported in the paper is negligible. So for a better comprehension of our paper we 
would prefer to maintain the original version of Graphical Abstract. Nonetheless, a Graphical 
Abstract modified according to the Reviewer’s suggestion is attached below to give the 
opportunity to the Reviewer to decide whether using the revised graphic or not. Notably, in Panel 
A (saturating light conditions) of the revised version of Graphical Abstract, the contribution of RPE 
cells in ROI production is represented as tentatively higher (big arrows) than those in Panel B (dim 
light condition, small arrows), because in our opinion the faster photransduction rates stimulated 
by saturating light illumination may increase RPE mitochondrial metabolism (and so ROI 
production) due to the higher energy demand necessary to accomplish the faster photo-pigment 
(11-cis retinal) renewal. However, we have no data about this fact, as we did not work on RPE, and 
therefore it is just our hypothesis. 
 
HIGHLIGHTS (3-5 BULLET POINT) 
 Saturating ambient light induces oxidative stress in the rod outer segments (OS) 
 Resveratrol and Metformin reduce radical production in OS 
 Positive correlation between light exposure and ROI production in OS in vitro 
 Modulating OXPHOS in OS may prevent cone loss secondary to rod damage  
*Highlights (for review)
*Graphical Abstract
MODULATION OF THE ROD OUTER SEGMENT AEROBIC METABOLISM 
DIMINISHES THE PRODUCTION OF RADICALS DUE TO LIGHT ABSORPTION. 
 
Daniela Calzia
1
, Paolo Degan
2
, Federico Caicci
3
, Maurizio Bruschi
4
, Lucia Manni
3
, Luca A. 
Ramenghi
5
, Giovanni Candiano
5
, Carlo Enrico Traverso
6
 and Isabella Panfoli
1
. 
 
1
Dipartimento di Farmacia-DIFAR,-Biochemistry Lab. University of Genoa, V.le Benedetto XV 3, 
Genova, Italy; 
2
 UOC Mutagenesi, IRCCS AOU San Martino – IST (Istituto Nazionale per la 
Ricerca sul Cancro); 
3
Department of Biology, Università di Padova, via U. Bassi 58/B, 35121 
Padova, Italy; 
4
 Laboratory of Pathophysiology of Uremia, Istituto Giannina Gaslini, Genova, Italy;, 
5
 Neonatal Intensive Care Unit, U.O.S. Malattie Metaboliche 
6
Clinica Oculistica, (DINOGMI) 
University of Genoa, V.le Benedetto XV 6, Genova, Italy. 
 
Corresponding Author:  
Prof. Daniela Calzia 
DIFAR-University of Genoa 
V.le Benedetto XV,3 
16132 GENOVA 
Phone + 39 010 353 7397 
Fax   + 39 010 353 8153 
dcalzia@gmail.com 
 
Abbreviations 
AMD, age-related macular degeneration; Ap5A, di(adenosine)-5-penta-phosphate; ATP synthase, 
FoF1-ATP synthase; ; DR, diabetic retinopathy;  ETC, electron transport chain; MTF, Metformin: 
*Revised Manuscript (text UNmarked)
Click here to view linked References
OS, outer segment; PUFA, polyunsaturated fatty acids; ROI, reactive oxygen intermediates; RP, 
retinitis pigmentosa; RV, resveratrol; TEM, transmission electron microscopy. 
  
ABSTRACT  
 
Oxidative stress is a primary risk factor for both inflammatory and degenerative retinopathies. 
Our previous data on blue light-irradiated retinas demonstrated an oxidative stress higher in the rod 
outer segment (OS) than in the inner limb, leading to impairment of the rod OS extra-mitochondrial 
aerobic metabolism.  
Here the oxidative metabolism and Reactive Oxygen Intermediates (ROI) production was 
evaluated in purified bovine rod OS in function of exposure to different illumination conditions.  A 
dose response was observed to varying light intensities and duration in terms of both ROI 
production and ATP synthesis. Pretreatment with resveratrol, inhibitor of F1Fo-ATP synthase, or 
metformin, inhibitor of the respiratory complex I, significantly diminished the ROI production. 
Metformin also diminished the rod OS Complex I activity and reduced the maximal OS response to 
light in ATP production.  
Data show for the first time the relationship existing in the rod OS between its -aerobic- 
metabolism, light absorption, and ROI production. A beneficial effect was exerted by metformin 
and resveratrol, in modulating the ROI production in the illuminated rod OS, suggestive of their 
beneficial action also in vivo. Data shed new light on preventative interventions for cone loss 
secondary to rod damage due to oxidative stress. 
 
 
Key Words:  ATP synthase; diabetic dim light; light; metformin; reactive oxygen intermediates; 
rod outer segment; resveratrol; oxidative stress. 
INTRODUCTION 
 
The Electron Transfer Chain (ETC) is a major producer of Reactive Oxygen Intermediates 
(ROI) [1,2], in turn responsible for the oxidative stress production, a set of alterations occurring in 
tissues, cells and macromolecules upon alteration of the physiological equilibrium between 
production and elimination of ROI. These, typically, trigger a vicious circle, since oxidative stress 
aggravates ROI production, causing hypo-metabolism, in turn lowering the ability of the cell to 
scavenge the damage. Markers of oxidative damage include malondialdehyde (MDA), and 4-
hydroxynonenal (4-HNE) [3]. The body's antioxidant defense capacity relies on different Vitamins 
and antioxidants  of both exogenous and endogenous origin among which polyphenols [4,5].  
The retina is the central nervous system (CNS) tissue displaying the highest oxygen (O2) 
consumption per gram of tissue [6], especially the outer retina adapted to darkness, particularly 
sensitive to damage by ROI. In fact, the rod OS membranes display an elevated content of 
polyunsaturated fatty acids (PUFA) [2,7].  In particular, photoreceptors consume about 4 times 
more O2 than the other neurons of the CNS, thereby comprising the retina [8]. Consistently, rod OS 
may be responsible for the high O2 consumption of the outer retina [6], as suggested by 
experimental evidence from biochemical proteomic and imaging analyses [9–12]. The ectopic 
expression of active of F1Fo-ATP synthase (ATP synthase), as well as electron transfer chain (ETC) 
in the rod disks points to the occurrence of an aerobic metabolism, devoted to providing ATP for 
photo-transduction. Notably, irradiation of organotypic eye cultures (explants) with short 
wavelength blue light (BL) elicited a larger ROI production in the rod OS, than in the IS [7]. 
Exposure to BL for 6 hours impaired the ETC and uncoupled ATP synthase, likely due to OXPHOS 
overwork caused by prolonged irradiation, with membrane damage. In fact, a dysfunctional 
oxidative phosphorylation increases the level of ROI [1].  
 ROI are believed to play a role in the aging process, both in acute and chronic conditions 
[13–15][16][4-6] . Furthermore, oxidative stress plays a central role in the retinal degenerations [17]  
[18] Retinal degenerative diseases include Age-related macular degeneration (AMD) [17] and 
diabetic retinopathy (DR) [19]. DR is a progressive complication during the course of type 1 or 2 
diabetes and the leading cause of blindness in developed countries [6,20]. About 60% of individuals 
with type 2 diabetes have some degree of retinopathy and develop initial DR within 20 years of 
diagnosis. DR is a microvascular disease, characterized by progressive changes in the retinal 
microvasculature with accompanying damage of neurons and Muller glial cells, that are eventually 
lost by apoptosis [6]. The ischemic retina releases growth factors that lead to pathological 
angiogenesis, neovascularization resulting in edema and intraretinal hemorrhages. A number of 
interrelated pathways that are the target of hyperglycemia are involved in the pathobiology of 
diabetic complications; among the most actively studied you include oxidative stress, the polyol 
pathway and the advanced glycation products (AGE) [21,22].  
The American diabetes Association (ADA) and the European Association for the Study of 
diabetes (EASD) recommend metformin (MTF) now used for more than 60 years, as a first-line 
therapy of type 2 diabetes mellitus in non-pregnant adults [23]. Its benefits include low-cost, 
minimum hypoglycemic risk, and a decrease in low-density lipoproteins (LDL) and glycated 
hemoglobin (HbA1c) levels. MTF improves insulin sensitivity in muscle and adipose tissue and 
suppresses hepatic gluconeogenesis mainly through activation of adenosine monophosphate-
activated protein kinase (AMPK) [24]. AMPK regulates metabolism and lipid biosynthesis, 
inactivates acetyl-CoA carboxylase and induces the expression of muscle hexokinase [25]. 
However, the metformin mechanism of action involved in insulin-sensitizing effects and bioactive 
lipids is not completely understood. By AMPK, MTF regulates metabolism and lipid biosynthesis, 
inactivating acetyl-CoA carboxylase and inducing the expression of muscle hexokinase [24]. MTF 
treatment improves insulin sensitivity and dyslipidemia, regulating the expression of the genes 
associated with lipid metabolism [26]  (also promoting hepatocyte and pancreatic β cell 
regeneration [27]. However, MTF suppresses liver glucose-6-phosphatase expression by AMPK-
independent mechanism involving complex I inhibition [28]. In fact, another MTF mechanism of 
action  is ETC Complex I activity inhibition [29], recently suggested to be its main action also in 
vivo [30] [31][32]. Resveratrol, a stilbene natural compound, was shown to act as an inhibitor of 
ATP synthase, and was shown to be able to inhibit the ectopic ATP synthase of the rod OS[33]. 
Here we present in vitro data on bovine rod OS homogenates showing, for the first time, a 
dependence of the rod OS aerobic metabolism and ROI production on absorbed light at varying 
intensities. We also report an increase in surface protein oxidation in the rod OS under saturating 
ambient light and show that both metformin and resveratrol can diminish the ROI production and 
the oxidative phosphorylation rates. 
 
MATERIAL AND METHODS 
 
Sample preparations 
Extraction of retinas 
Retinas were extracted as previously described [34]. Briefly, the eye semicup, including the 
retina, from freshly enucleated bovine eyes (from a local certified slaughterhouse) after vitreous and 
lens removal, were incubated for 10 min with Mammalian Ringer (MR, 0.157 M NaCl, 5 mM KCl, 
7 mM Na2HPO4, 8 mM NaH2PO4, 0.5 mM MgCl2, 2 mM CaCl2 pH 6.9 plus protease inhibitor 
cocktail (Sigma-Aldrich, S. Louis, MO, USA) and 50 g/ml Ampicillin). Each retina was then cut 
free of the optic nerve with scissors and collected. 
Purified bovine rod OS preparations 
Purified bovine rod OS were prepared under dim red light at 4 °C from 14 retinas, by 
sucrose/Ficoll continuous gradient centrifugation [12] [35]in the presence of protease inhibitor 
cocktail (Sigma–Aldrich, S. Louis, MO) and ampicillin (100 µg/ml). Rod OS preparation were 
characterized for integrity of plasma membrane as reported[35]. Rod OS homogenates were 
obtained by Potter-Elveheim homogenization on ice in 1:1 (w/v) hypotonic medium (5 mM Tris-
HCl, pH 7.4 plus protease inhibitor cocktail and 100 µg/ml ampicillin).  
Osmotically intact rod OS disk preparations 
Osmotically intact disks were prepared by Ficoll flotation [36] from purified rod OS. After 
letting the rod OS burst for 3 h in 5% Ficoll solution with 70µg/ml leupeptin, and 100µg/ml 
ampicillin, at 4°C 2 ml of distilled water were layered onto Ficoll and sample centrifuged for 2 h at 
25,000 rpm in a Beckman FW-27 rotor (100.000 x g). Disks were collected in the distilled water 
phase, under sterile conditions. Both purification procedures were carried out in the absence of 
Cyclosporin A and 2-Aminoethoxydiphenyl borate. These are inhibitors of the mitochondrial 
permeability transition pore (MTP)[37,38]. Such conditions therefore would promote the MTP 
formation in contaminant mitochondria, if any, so that these would not be functional. 
Transmission Electron Microscopy 
The front half of bovine eyes were excised and the vitreous humor and lens removed. The 
eye cups were then filled with fixative consisting of 4% paraformaldehyde and 0.1% glutaraldehyde 
in PBS buffer solution. After fixation (1,5 hr), retinas were removed from the eye capsule, cut into 
small pieces, washed overnight with 50 mM NH4Cl, dehydrated and embedded in LR White Resin 
[39] and polymerized at 58°C. Ultrathin sections were placed on Formvar-coated nickel grids and 
used the next day for immunogold labeling. 
For immunostaining of sections, the postembedding immunogold method was applied. 
Sections were treated with blocking solution (1%BSA, 0.1% Tween 20, PBS 1X), then incubated 
with mouse monoclonal anti-rhodopsin (1:100) (Sigma Aldrich, St.Louis, MO, USA) and rabbit 
polyclonal anti-ND1 subunit of ETC I Antibody (Ab) (diluted 1:50) (Abcam, Cambridge, UK) 
overnight at 4°C. Ab binding was detected using secondary anti-rabbit IgG (British BioCell 
International) (diluted 1:100) coupled to gold particles (25) nm, and goat anti-mouse IgG (British 
BioCell International) (diluted 1:100) coupled to gold particles (5 nm). Sections were analyzed at a 
FEI Tecnai G12 transmission electron microscope operating at 100KV. In negative controls the 
preimmune serum was applied to the sections instead of the specific primary Ab. Images were 
acquired with OSIS Veleta cameras, collected and typeset in Corel Draw X4. Controls were 
performed by omitting primary Ab, which resulted in absence of crossreactivity (data not shown).  
Light exposure conditions for cytofluorimetric and ATP synthesis assay. 
For cytofluorimetric measurements and ATP production assays, rod OS were subjected to 
the following illumination conditions:  i) dim light; ii) saturating ambient light exposure for 5 
minutes; iii) saturating ambient light exposure  for 1 hour under a lens filter (lens filters, belonging 
to category 3  defined by NBR15111 Maximum value of spectral transmittance is 1 tV Maximum 
value of solar UVA transmittance (315-380 nm) is 0,5 tV Visible Light Transmission (VLT) is from 
8% to 18%.) (according to: ABNT. Protec¸a˜o pessoal dos olhos – Oculos de sol e filtros de 
protec¸a˜o contra raios solares para uso geral. NBR15111/2004. Associaca˜o Brasileira de Normas 
Te´cnicas ,2004), to mimic human sunglass wearing conditions; iv)  saturating ambient light 
exposure for 1 hour. For oxygen consumption assay rod OS were treated with ambient-sunlight 
exposure for 1 hour or to dim light.  
ROI production assay by cytofluorimetric measurements 
Cytofluorimetric measurements of ROI production in the rod OS was performed using 
dihydrorhodamine 123 (DHR) probe (Molecular Probes, Life Technologies). Changes in ROI 
production can be evaluated. Rod OS (40 µg) treated as above specified  were washed in phosphate-
buffered saline (PBS) and resuspended in 50 ml HEPES buffer (10 mM HEPES, 135 mM NaCl, 
5mM CaCl2) and stained for 20 minutes with DHR (2.5 mg/mL) and kept at room temperature, 
washed with PBS and re-suspended in a total volume of 400 µl of PBS. Flow cytometry was 
performed in a CyAn ADP cytometer (Beckman Coulter) equipped with three laser lamps. The plot 
of all physical parameters (forward scatter (FSC) versus side scatter (SSC) is used to set the gate 
that limits debris and aggregates. When necessary, isolated rod OS were preincubated with 30 µM 
Resveratrol (RV) for 15 minutes or 5 mM MTF for 2 hours 
Spectrophotometric assay of rod OS Complex I activity 
Complex I (NADH-ubiquinone oxidoreductase) activity was measured on 50µg of protein 
following the reduction of ferricyanide at 420nm [40]. A molar absorption coefficient of 1 (mM−1 
cm−1) at 420 nm was used. Measurements were conducted on a double beam spectrophotometer 
(UNICAM UV2, Analytical S.n.c.). 
Surface protein oxidation assay  
Rod outer segment disks (100 µg) were washed in 20 mM Phosphate, 150 mM Nacl, 5 mM 
EDTA at 6,8 pH was exposed or not at the light for 10 min. Then samples were labeled with EZ-
link Maleimide PEG2-biotin (Thermo Scientific) overnight at 4°C in a dark box. Oxidative positive 
control was done treating the sample with 5 mM H2O2 and then labelling with biotin probe. Excess 
of probe was removed from the samples by micro-dialysis using 100-500 Da membrane 
(SpectrumLab). Finally the samples were transferred to nitrocellulose membrane using a Dot-Blot 
apparatus (Bio-Rad, Hercules, CA). Membranes were saturated in 5% BSA, rise and incubated with 
1:10000 neutravidin HRP conjgate (Thermo Scientific) in 1% w/v BSA, PBS and Tween 0.05% 
v/v. Chemiluminescence was used for detection and image was acquired with the ChemiDoc Touch 
Imaging System (Bio-Rad). Quantitative densitometry was performed using Image Lab software 
(Bio-Rad).  
ATP synthesis assay in rod OS 
The formation  of ATP from ADP and inorganic phosphate (Pi) was assayed in purified rod 
OS (0.04 mg protein/ml) treated as above specified  according to Mangiullo et al. [41] and as 
reported previously (Calzia et al., 2013). Rod OS were incubated for 5 min at 37 °C in 50 mM 
Tris/HCl (pH 7.4), 5 mM KCl, 1 mM EGTA, 5 mM MgCl2, 0.6 mM ouabain, 0.25 mM 
di(adenosine)-5-penta-phosphate (Ap5A, adenylate kinase inhibitor), and 25µg/ml ampicillin. ATP 
synthesis was induced by addition of: 5 mM KH2PO4, 10 mM glucose and 0.1 mM ADP at the 
same pH of the mixture. After stopping the reaction with 7% perchloric acid final concentration, 
and neutralizing samples with K2CO3 the ATP concentration was measured in a luminometer 
(Lumi-Scint, Bioscan) by the luciferin/luciferase chemiluminescent method. Calibration was done 
with ATP standard solutions (Roche Diagnostics Corp., Indianapolis, IN) between 10
−9
 and 10
−7
M. 
When necessary, isolated rod OS were preincubated with 30 µM RV for 15 minutes or 5 mM MTF 
for 2 hours. 
Oxygraphic measurements 
O2 consumption by rod OS (0.04 mg protein/1.7 ml) was measured at 23 °C in a closed 
chamber, using a thermostatically controlled oxygraph equipped with an amperometric electrode 
(Unisense–Microrespiration, Unisense A/S, Denmark) under continuous electromagnetic stirring 
(Calzia et al., 2013). A specific software (MicOx, Unisense) was used to convert data in Excel files. 
Rod OS were previously diluted 3:1 in ultrapure water, then added to the mixture by means of a 
Hamilton syringe, which granted a partial disruption of rod OS, allowing substrates to permeate. 
Incubation medium was: 50 mM HEPES pH 7.3, 100 mM KCl, 2 mM MgCl2, 5 mM KH2PO4, 25 
μg/ml ampicillin, and 0.3 mM di(adenosine-5′) penta-phosphate to inhibit adenylate kinase (Aicardi 
and Solaini, 1982). Respiring substrate was 5 mM glucose. When necessary, rod OS were 
preincubated with 5 mM MTF for 2 hours 
Data analysis 
Results are expressed as mean ± SD and n refers to the number of assays in any particular 
condition. In ATP synthesis, statistical analysis was performed using Student’s t-test to compare 
data obtained using different light conditions and ATP synthase inhibitors (resveratrol and 
Metformin). Results were considered significant if P < 0.05. 
Materials 
Ampicillin, Ap5A, metformin, and resveratrol were all supplied by Sigma-Aldrich (St. Louis, MO, 
USA 
 
RESULTS 
 
The complex of our previous biochemical and imaging data suggests that an ATP synthesis 
and O2 consumption sensitive to classical mitochondrial inhibitors, and to polyphenols as inhibitors 
of FoF1-ATP synthase, are detectable in rod OS, which are devoid of mitochondria.  The rod OS 
may be regarded as a “specialized kind of mitochondrion", displaying active Electron transport 
Chain (ETC) complexes and a transmembrane electrochemical proton gradient [9]. 
A TEM characterization of a bovine retina confirms that ETC complex I is an integral part 
of the disk membranes. Figure 1 showing  immunogold colocalization experiment on bovine retina 
with antibodies (Ab) against Rh (5 nm diameter gold particles) and ND1 subunit of complex I (25 
nm diameter gold particles) reports that ND1 is expressed not only in mitochondria, as expected, 
but also in rod OS. Panel A shows an over view of a labelled bovine retina, while Panel B and C are  
magnifications of a mitochondria and a portion of a rod OS respectively, included in Panel A. 
Colocalization of  Rh and ND1 is more visible in Panel D and its inset, that are a magnification of a 
portion of a rod OS included in the black squares in Panel C and Panel D, respectively. 
The ROI production in a suspension of rod OS homogenized homogenates (subjected to 
shearing to avoid large aggregates) in the presence of various substrates was studied by flow 
cytometry, in the presence of a dihydrorhodamine 123 (DHR). This probe can detect the presence of 
ROI, in particular H2O2 and superoxide [42]. In saturating ambient light a significant production of 
ROI was detected in rod OS, which increased in parallel with the time of sample incubation with 
respiring substrates (Glucose or NADH + succinate) and even in their absence (Figure 2). On the 
other hand, in dim light, the best condition to activate rod signaling, ROI production was negligible 
in the presence of the same substrates. Moreover, pre-treating rod OS with Resveratrol (RV) for 15 
min in the same experimental conditions, a significant decrease in intracellular ROI production was 
observed especially under light conditions. Notably, in dim light DHR signal was similar in 
untreated and treated samples. 
Considering that a main action of Metformin (MTF) has been reported to be the inhibition of 
Complex I of the ETC [32], we tested the effect of MTF also on  extramitochondrial ETC Complex 
I activity in rod OS. Complex I activity in rod OS accounted for about 1,51 ± 0.2 IU/mg of total 
protein (µmol of reduced ferricyanide/min/mg). Upon preincubation with MTF for 2 hours 
Complex I activity decreased to 0.77±0.08 IU/mg of total protein with an inhibition of about 50%, 
consistently with its inhibitory actin on Complex I [32]. Moreover we studied the effect of an 
incubation with MTF (5 mM) on of ROI production and ATP synthesis in the rod OS, both in dim 
and ambient light varying  intensity using a lens filter (see Material and methods section) and time 
of exposure (Figure 3). In the presence of glucose, at intermediate light intensity after 1 hour of 
saturating ambient light exposure under lens filters (Figure 3) (see Materials and Method section), 
ROI production was slightly lower (although not as low as in dim light) than after exposure to 
saturating ambient light for the same period of time. On the other hand, interestingly, after 5 
minutes of saturating ambient light exposure, ROI production was similar to that in dim light and 
therefore consistently lower than after 1 hour of saturating ambient light. Moreover, rod OS 
preincubated with MTF produced significantly less ROI in all conditions tested, with respect to 
untreated samples (Figure3). In saturating ambient light, preincubation with N-acetyl-L-cysteine 
(NAC), an antioxidant acting as a precursor to glutathione restoring GSH levels, inhibited ROI 
production by 37% . 
Considering that the ETC is embedded into the rod OS disk membranes, to further test the actual 
site of oxidative stress, purified disks were assayed for the presence of oxidized proteins by the EZ-
linked Maleimide PEG2-biotin assay, that labeled reduced thiols (sulfhydryl groups,—SH) of the 
disk surface protein. Densitometric analysis showed that the signal of samples exposed to ambient 
light in the same experimental conditions was significantly lower than that of disks in dim light. 
Disks treated with H2O2, used as positive control, showed a negligible signal corresponding to a 
maximal oxidation state of the sample (Figure 4).   
In the presence of glucose as a respiring substrate, the ATP synthesis in the rod OS was assayed 
varying light intensity and time of exposure (see Materials and Method section) in the presence or 
absence of MTF. Results are shown in Figure 5. It can be noted that the difference in rod OS ATP 
synthesis after 1 hour of saturating ambient light exposure with respect to dim light was higher than 
after 1 hour of saturating ambient light exposure under lens filter. On the other hand, interestingly 
after 5 minutes of light exposure, ATP production was already similar to that after 1 hour of 
saturating light exposure. The presence of MTF depressed ATP synthesis by about 70% in 
saturating ambient light, 46% in dim light and about 50% after 5 minutes of saturating ambient light 
exposure or under lens filters, suggesting that this probably depends considerably on the activity of 
Complex I. 
O2 consumption assay can follow the whole process resulting from the transfer of electrons to O2 by 
the ETC with the consumption of the proton gradient with aerobic ATP synthesis from added ADP. 
In this case the difference between the conditions of light and dark was more pronounced. Figure. 6 
Panel A, shows a representative amperometric graph of the O2 consumption in coupled conditions 
by the rod OS homogenates subjected to saturating ambient light for 1 hour, O2 consumption 
increases in the presence of substrates (glucose 5 mM) and then by addition of ADP (0.3 mM). 
Panel B shows a representative experiment conducted under the same conditions of Panel A, but in 
dim light. O2 consumption was reduced, as a result of the lower energy requirement.  
Panel C and d are oximetric traces of O2 consumption in the rod OS pre-treated for 2 hours with of 
MTF under saturating ambient light and dim light respectively. The effect of MTF, which limits the 
ROI production modulating the ATP synthase, shows a little decrease in O2 consumption more 
evident under light condition than in dim light, as showed in Table 1 reporting the mean O2 
consumption in rod OS treated or not with MTF under saturating light or dim light. 
By subjecting the discs to saturating light (Panel C) an uncoupling was observed, probably due to 
an oxidative damage of the disc membrane by prolonged exposure light which dissipates the proton 
gradient 
  
DISCUSSION   
The main result of the present work is the finding of a correlation among light absorption, 
aerobic metabolism and oxidative stress in the rod OS, with a significant impact on the current 
understanding of the photoreceptor rod OS physiology. This is, to the best of our knowledge, the 
first study able to show that the photo-transduction functioning in the rod OS, consequent to light 
absorption at varying intensities, requires an increase in ATP production and O2 consumption and 
can elicit an increase in ROI production, with respect to dim light conditions. The rod OS 
metabolism would in fact be oxidative, as suggested by data on ATP synthesis and O2 consumption, 
and the ectopic functional expression of ND1 (Figure 1), consistently to previous proteomic and 
biochemical data [43,44]. On the other hand, the ectopic expression of the ETC and FoF1-ATP 
synthase would not be exclusive of the rod OS (reviewed in [45][46]). Notably, it is undeniable that 
the ETC, especially Complex I, is a main source of ROI production [47]. 
It was reported that the expected increase in glycolytic flux in the rod OS (currently believed 
to contribute exclusively to ATP supply therein) upon light absorption, could not be observed [48]. 
Maximum glycolitytc production in the light was 84 uM of ATP/s, lower than the energy cost of the 
visual process, estimated to range around 127 uM ATP/s [48,49]. On the other hand, ATP diffusion 
through the cylium seems unlikely [50], when considering that only the distal disks are active in 
phototransduction, being devoid of cholesterol [43].  
The unexpected consistent ROI production observed in the rod OS in vitro in function of the 
time and intensity of light exposure and also proportional to the length of exposure to the respiring 
substrates, i.e. the physiological rod OS functioning conditions. Lowering light intensity (i.e. for 1 
hour under a lens filter) ROI production and ATP synthesis decrease respect to those after 
saturating ambient light exposure for 1 hour, while interestingly after 5 minutes of saturating 
ambient light exposure ATP production was already similar to that after 1 hour of light exposure, 
ROI production is similar to that in dim light and so consistently lower than after 1 hour of 
saturating ambient light. This may mean that to support the energy demand of phototrasduction 
saturating ambient light induces ATP synthesis increasing respect to dim light by 5 minutes of 
exposure but this time is not enough to elicit oxidative stress production. This suggests that the ROI 
production inside rod OS is not an instantaneous, but cumulative phenomenon, due to the increasing 
commitment of physiologically active oxidative phosphorylation in the rod disk membranes, 
especially detectable in in vitro conditions that limit the ability of the cell to scavenge ROI. 
Results are very interesting, in that they show that the ROI production more than the ATP synthesis 
is the most sensitive index of involvement of OXPHOS in the light-induced photo-transduction.  
In vitro, in the absence of the dioptric means of the eye, light may overstimulate the OS 
causing phototransduction and ETC overwork, with increased ROI production. Moreover, 
homogenization dilutes the rod OS cytosol, rendering antioxidant systems less efficient.  
Vision, OXPHOS and ROI appear to be inextricably intertwined: light increases cGMP 
turnover, and hence ATP demand, conceivably sustained by the ectopic OXPHOS, main producer 
of ROI.  It was shown that irradiation of mouse eye explants with blue light (405 nm) (a model of 
AMD) for 6 hours, causes a considerable retinal oxidative stress more intense in the OS than in the 
IS [7,51]. In those extreme illumination conditions there was a dramatic late impairment of ATP 
production and O2 consumption, likely as the result of disk membrane peroxidation [52][7] , 
causing cytochrome c  to escape the disk, activating the apoptosome [53]. It is known that sustained 
illumination causes irreversible damage, and photoreceptor apoptosis [54].  
Data imply that the Retinal pigmented epithelium (RPE) mitochondria, currently believed to 
be the main source of ROI for the rod OS, may not play this role, being instead the rod OS the main 
ROI producer. The rod OS would house an important potential source of ROI, being therefore prone 
to oxidative stress as its membranes are enriched with polyunsaturated fatty acids. Thus, the rod OS 
in vitro appear a good model of light damage, useful to understand the molecular basis of the 
generation of oxidative stress inside the rod, common denominator of retinopathies [6,12] [55]. 
Retinal diseases have oxidative stress as an etiopathogenetic moment [56,57]. It has been 
demonstrated that the oxidative stress is among the risk factors contributing to the pathogenesis of 
retinopathy of prematurity (ROP), and also the degenerative retinal dystrophies. Incidence of ROP, 
a major cause of blindness especially in premature infants, exposed to conditions of systemic 
oxidative stress, having poorly developed antioxidant systems [58]. The main contributing factors in 
the pathogenesis of ROP would be hypoxia, hyperoxia and reperfusion damage [59].  
Degenerative retinopathies are expected to constitute a serious medical problem in the next 
future, with significant economic implications [17,60]. The human retinal dystrophies are currently 
irreversible. Therapies are focused on delaying the onset or progression [61]. One approach is 
aimed at preventing cell death, for example by administering neurotrophic compounds, among 
which antioxidants, to prolong the viability of retinal cells [62]. In this context, the effectiveness of 
resveratrol, a polyphenol present in many natural compounds, in scavenging ROI production in the 
rod OS homogenates is promising and consistent with its protective action in many animal models 
of retinal damage [10] . In fact, slowing down the degenerative process by modulating the ROI 
production inside the rod OS may be crucial in all stages of the disease.  
Increased oxidative stress is one of the common pathogenic factors of diabetic retinopathy 
(DR) one of the main diabetic disease complications. In particular hyperglycemia is a cause of 
overproduction of superoxide anion, although mechanisms by which hyperglycemia increases 
oxidative stress are not fully understood [63]. In addition, recent studies have identified 
abnormalities in diabetic patients in the retinal neurons before the marks of microvascular changes. 
DR Patients usually show reduced responses in multifocal electroretinography, decreased sensitivity 
to blue-green color, and contrast, before microvascular injury, suggesting that the damage to 
photoreceptors is the “primum movens”. Here we have tested the action of metformin (MTF) the 
first-line therapy for type 2 diabetes. The best known mechanism of MTF action, is activation of 
AMPK [24,26,27]. However, besides its hypoglycemic and metabolic effects recently MTF 
inhibitory action on mitochondrial complex I has received attention and has also been indicated as 
its main action [31] [32]. 
MTF intracellular transport is mediated by isoforms of the organic cation transporters (OCT), but 
within the cytosol, the ETC would be the primary objective of MTF [64].  Notably, data show that 
MTF is able to inhibit ectopic Complex I in rod OS and significantly diminish the production of 
ROI levels in the rod OS, as a probable consequence of its inhibitory action on Complex I [32]. 
MTF would produce a decrease in NADH oxidation, proton pumping, and consumption of O2, with 
reduction of ATP synthesis and hypometabolism. This is consistent with the reports that MTF 
produces a hepatic depletion of ATP, also reducing the lipogenesis. It appears that the use of MTF 
in patients suffering from type 2 DM, and thus likely also from DR, may reduce the of cumulative 
oxidative risk damage.  
Conclusions 
The increase in energy demand for phototransduction in varying ambient light conditions 
and the consequent overfunctioning of ETC would causes increased oxidative stress rates, 
representing a major risk factor for retinopathies, both inflammatory and degenerative such as 
ROPDR and AMD, respectively. 
Moreover although the human retina also contains cones, not studied here, the rods are vital, 
as the dystrophies always start with the loss of the rods, which irreversibly causes the death of 
cones. In fact, rods produce a cone survival factor, called rod-derived cone viability factor 
(RdCVF), which was identified as a truncated thioredoxin-like protein encoded by the 
nucleoredoxin-like-1 gene (NXNL1) [65]. Rod-driven cone death,  triggered by the loss of RdCVF 
expression, appears to be the first phase of the disease [66] . In fact, rod survival is a crucial point in 
rod-cone dystrophies, such as AMD and retinitis pigmentosa (RP) where first loss of ability to see 
in dim light conditions due to degeneration of rod photoreceptors was observed and then  central 
vision was compromised caused by a loss of cone function with a potentially complete blindness. 
RdCVF injection in animal models of RP prevented the shortening of cone outer segments which 
precedes cone loss [67]. 
A prevention of cone secondary loss by intravitreal administration of RdCVF is one of the 
latest therapies bearing a nice clinical rational, even though many patients have already lost most of 
the rods when consulting an ophthalmologist. Unfortunately, visual acuity is subjectively reduced 
when more than 50 % of cones become non-functional, a late phase [68].. Therefore again it 
appears of vital importance to be able on one hand to “take care of the rods”[69] with accurate 
screening of occurrence of hemeralopia and, on the other hand, to implement preventative strategies 
allowing to modulate the ROI production in the rod. It is tempting to presume that also antioxidants 
may be administered intravitreally.   
However, any approach of this kind can only be accomplished when the awareness of the 
oxidative risk that exists in the retinal rod OS due to the presence of an oxidative metabolism 
supported by the expression of ETC and ATP synthase, unknown to date, will have been achieved. 
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FIGURE LEGENDS 
Figure 1. Transmission Electron Microscopy (TEM) on bovine retina.  
Panel A. Bovine retina double-labelled with antibodies anti-Rh (small, 5 nm width gold particles) 
and anti-ND1 (large, 25 nm width gold particles). IS: inner segment; m: mitochondrion; OS: rod 
outer segment. Panel B: enlarged area of Panel A to show a detail of a mitochondrion in rod inner 
segment (IS) labelled with anti-ND1 (arrow). Panel C: enlarged area of Panel A showing the rod 
OS, characterized by co-localization of Rh signal and ND1 signal (arrows). Panel D: enlarged area 
of Panel C to show a magnification of the rod OS, expressing both rhodamine (arrowheads) and 
ND1 (arrows). Inset in Panel D: detail of a large gold particle (indicating the presence of ND1) 
close to two smaller ones (indicating the presence of Rh; arrowheads). 
Figure 2. ROI production in rod OS in light or dim light.  
Kinetic of the increase in ROI production in rod OS incubated in presence of respiring substrates: 
NADH (0.29mM) +succinate (20mM) (Panel A) or glucose (20mM) (Panel B) under ambient light 
(1 h) or dim light. ROI production was measured following oxidation of the dye rhodamine 123. 
The reaction kinetic was also followed for both reaction mixtures in presence of ATP synthase 
inhibitor Resveratrol (RV) . 
Figure 3. Effect of Metformin (MTF) on ROI production in rod OS in different light 
conditions Kinetic of the increase in ROI production in rod OS under ambient light (1 hour or 5 
minutes), dim light, ambient light under lens filter (1 h) in presence of glucose (20mM). ROI 
production was measured following oxidation of the dye rhodamine 123. The reaction kinetic was 
also followed for both reaction mixtures in presence of MTF . 
Figure 4. Oxidation of disks surface proteins by EZ-link Maleimide PEG2-biotin labeling.   
Rod OS disks g) exposed to dim light or saturating ambient light or treated with 5mM H2O2 
(as positive control) were labeled with EZ-link Maleimide PEG2-biotin o.n. at 4°C in dark box and 
transferred on nitrocellulose. Protein oxidation was revealed with neutravidin HRP conjugate. 
Figure 5.. ATP synthesis in rod OS under dim light or different conditions of ambient light 
exposure  
ATP synthesis was tested in the presence or absence of MTF under ambient light (1 hour or 5 
minutes), dim light, ambient light under lens filter (1 h) .Histogram shows ATP formation in rod OS 
MTF 
inhibited ATP production in all conditions. Data shown are means ± SD n = 4. *P < 0.01, paired 
Student’s t-test. 
Figure 6. Oxygen consumption in rod OS under saturating ambient light or dim light.   
Representative amperometric tracing of O2 consumption in coupled conditions in purifed rod OS 
homogenates (0.04 mg total protein) irradiated with ambient light for 1 h (Panel A); or in dim light 
(Panel B);  ambient light plus MTF (Panel C); dim light plus MTF (Panel D) Additions: Glucose (5 
mM); ADP (0.3 mM), in 1.7 ml volume.  
 
Table 2 Oxygen consumption by rod OS under saturating ambient light or dim light 
Table reports the coupled respiration rates in rod OS (0.05 mg total protein) under saturating 
ambient light (light) or dim light in the presence or absence of Metformin (MTF).  To stimulate O2 
consumption Glucose (5mM) was added. Data are the mean ± SD of four experiments. 
 
 
 Light Dim light 
 Glucose ADP Glucose ADP 
OS 172.72±25.91 195.42±29.54 117.64±15.29 153.68±22.85 
OS+MTF 91.8±11.93 111.52±15.61 63.24±8.85 106.76±13.78 
Table 1
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